Genome Engineering with TALE and CRISPR Systems in Neuroscience

Area of Science:

• Genetics and Genomics
• Neuroscience
• Molecular Biology

Background:

• Genome engineering technologies are rapidly advancing biological research.
• Programmable DNA-binding agents (PDBAs) are increasingly utilized in scientific studies.
• These tools offer novel approaches for investigating complex biological questions.

Purpose of the Study:

• To review recent advancements in genome engineering technologies.
• To discuss the potential applications of these technologies in neuroscience.
• To highlight the impact of genome engineering on basic and clinical neuroscience research.

Main Methods:

• Focus on programmable DNA-binding agents (PDBAs).
• Discuss transcription activator-like effector (TALE) systems.
• Explain RNA-guided clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR associated (Cas) systems.
• Mention fusion or co-expression with effector domains for gene modification.

Main Results:

• PDBAs allow precise modification of genomic sequences.
• These technologies enable control over gene expression levels.
• Genome engineering extends classic gene targeting methods.

Conclusions:

• Genome engineering provides powerful new tools for neuroscience.
• These advancements facilitate novel methodologies for critical research questions.
• The potential applications span both basic and clinical neuroscience fields.